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Abstract. Soybeans are a main source of plant lipoxygenases and also important sources of 
isoflavone, including free genistein, daidzein, glycitein and their acetyl, malonyl and glucosilated 
forms. The enzymatic extract from soybeans (LE) rich in lipoxygenase was checked for the presence 
of polyphenols through LC-UV-DAD and LC-ESI –MS analysis. LE contains malonyl daidzin and 
genistein but the amounts in which these are present are very low.  
 




Isoflavones are a class of phytoestrogens—plant-derived compounds with estrogenic 
activity. Isoflavones are produced almost exclusively by the members of the 
Fabaceae/Leguminosae (bean) family. Isoflavones are phenolic compounds containing 
flavone nucleus, which is composed of 2 benzene rings (A and B) linked through a 
heterocyclic pyrane C ring. The position of the B ring discriminate flavonoid flavones (C2-
position) from isoflavones (C3-position) (Vicaş et al, 2009). Soybeans are important sources 
of isoflavone levels (Song et al, 1998), present as 12 derivatives, including free genistein, 
daidzein, glycitein and their acetyl, malonyl or glucosilated forms and also a main source of 
plant lipoxygenases.  
 
 




The impact of dietary isoflavones, respectively daidzein and genistein, on the health of 
adults and infants is well documented. An increasing interest for these compounds is 
registered due to their biological effects including: estrogen-like activity, antioxidant activity 
(Arora et al, 1998; Patel et al, 2001; Malencić et al, 2007; Sakthivelu et al, 2008) prevention 
of breast (Warri et al, 2008), prostate (Wang, 2002; Matsumura et al, 2008) and colon  cancer 
(Mac Donald et al, 2005), prevention of heart disease (Lichtenstein 1998; Xiao 2008) of 
menopausal symptoms and osteoporosis (Potter et al, 1998; Messina, 2007; Ma et al, 2008). 
In this study the enzymatic extract from soybeans (LE) was analyzed through LC-UV-
DAD and LC-ESI -MS and the quantitative analysis of its components was also performed.  
 
MATERIALS AND METHODS 
 
Extraction of lipoxygenases from soybeans (LE) 
To obtain the lipoxygenase extract (LE) an aliquot of 5 g soybean meal was mixed 
with 30 mL of PBS, pH 7.0, and stirred for 1 h at room temperature. It was then filtered 
through cheesecloth and centrifuged for 10 min at 16.000 rpm. The supernatant represents the 
raw extract LE. 
Extraction of phenolic compounds by Solide Phase Extraction (SPE) 
In brief, 1.500 ± 0.001 g of polyphenolic extract were weighed into pear shaped flasks, 
and 0.500 ml of the internal standard solution (0.01 mg/ml of methanolic solution of ortho-
coumaric acid) was added. The solvent was evaporated (in rotary evaporator at 30 ºC under 
vacuum) and the samples were dissolved in 10 ml of methanol. The extraction was performed 
using diol-bonded SPE
 
cartridges (GracePure SPE Diol 500mg/3ml) previously conditioned 
with 6 ml methanol. The phenolic fraction was eluted with 10 ml methanol. After evaporating 
the solvent in a rotary evaporator at t=30°C, the residues were reconstituted in a 500µl 
methanol:water 1:1, v/v) and filtered over a 0.45 µm pore size filter for LC-MS analysis (PE). 
Vials were covered with aluminum foil to protect phenolic compounds from light exposure 
(Chedea et al, 2009).  
 
HPLC-UV-DAD and HPLC-MS-ESI analysis 
An Agilent 1100 LC-MSD System controlled by Agilent software v. A. 09.03 (Agilent 
Technologies, Waldbronn, Germany) equipped with a Vacuum degasser, a quaternary pump, 
an autosampler, a DAD variable wavelength detector 1100, 6-port autoinjector valve, was 
used for the HPLC-UV-DAD analysis. The HPLC analysis were performed using an 
octadecyl column, Phenomenex Luna C18 column, 100Å (4.6 mm i.d.× 250 mm; particle size 
10µm), maintained at 35°C coupled with a Phenomenex C18 (ODS, Octadecyl) security 
guard column. Determination of phenolic compounds was carried out at 220, 280 and 320 nm. 
To prove the absence vs presence of anthocyans, reading was also performed at 520 nm 
(Chedea et al, 2009).  
HPLC separation efficiency was optimized with different solvent ratios using different 
gradient conditions with water, methanol and acetonitrile, flow of 1ml/min and injection 
volume of 20µl. The mobile phase consisted of 95.0 % water (0.2% acetic acid), methanol 
(2.5%) and acetonitrile (2.5%). Gradient elution for the HPLC separation is explained in Tab. 








Ternary mobile reversed phase gradient of the HPLC method (Chedea et al, 2009) 
 

























aMobile phase A: a mixture of 0.2% acetic acid in water with pH= 3.1 
bMobile phase: acetonitrile 
cMobile phase: methanol 
Mobile phase B was a 1:1 mixture of b:c 
 
LC-MSD, Agilent 1100 mass spectrometry system (ESI), was used for detection and 
characterization of metabolites, using both negative and positive mode with a heated capillary 
at 350ºC  and voltage of 4.1kV, nebulizer pressure 50.0 psi, a carrier gas flow (nitrogen) of 13 
l/min. The full scan mass spectra of the phenolic compounds were measured from m/z 100 up 
to m/z 1000 (Chedea et al, 2009).  
Quantification, repeatability, recovery 
Quantification was performed using catechin as standards. A calibration curve was 
made over the range of 0.02 – 0.1 mg/ml (6 calibration points) of pure standard, diluted in 
HPLC grade methanol and the samples were analyzed in triplicate. The equation obtained for 
the catechin standard curve was y=12279x-38.679, r2=0.99. Recovery through the SPE was 
calculated using o-cumaric acid as standard. In this case, the recovery was 102% (Chedea et 
al, 2009).  
 
RESULTS AND DISCUSSION 
 
 Fig. 2 shows the LC-MS chromatogram of the LE extract recorded at 280 nm for the 
representative compounds of the extract together with the ionic MS fragmentation and UV-
Vis spectra. The compounds were identified by retention time (tR), UV spectrum (obtained 
from DAD) and MS spectrum (obtained from ESI detector). The structure of the reported 
compounds for the identified compounds has been tentatively assigned on the basis of 
previous citations in the literature (Klejdus et al, 2004; Heimler et al, 2004; Otieno and Shah, 
2007; Deavours and Dixon, 2005).  
The 3 isoflavones daidzein, glycitein, and genistein are each found in soy in 4 forms. 
In the soybean, the 6″-O-malonyl-β-glucosides of the isoflavones are the predominant forms. 
The 6″-O-acetyl-β-glucoside-, β-glucoside, and aglycone forms arise from degradation of the 
6″-O-malonyl-β-glucosides during processing of soybeans and soy foods or during sample 
preparation and analysis (Collison, 2008). The fragmentation pattern of free genistein and 
daidzein malonylglucoside shows signals at m/z 269, and at m/z 501 and 253 respectively 
similar to those described by Heimler et al., 2004. 
The identified compounds were tentatively identified as being 6″-O-malonyl-β-
glucoside of daidzein (tR=28,16) and the agluconic genistein (tR=34,81), isoflavones known to 
be important bioactive compounds in soy beans. The UV-Vis absorption maxima for the 
spectra of malonyl daidzin were at 248 nm and 308 nm and for genistein at 260 nm. 
262 
 
The quantitative analysis based on spectrophotometric determination (UV-DAD) gave 




The analysed LE contains the glucosilated form of daidzein- the malonyl daidzin and 
free genistein but the amounts in which these are present are very low.  
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Fig. 2. LE chromatogram at 280 nm obtained by LC-MS analysis, showing the presence of the most important compounds, 6″-O-malonyl-β-glucoside 
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